Editing Acetylation and Protein Homeostasis
Editing Acetylation and Protein Homeostasis
批准号:
10272903
负责人:
George Burslem
金额:
$40.63万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-08-01 至 2026-05-31
关键词:
AcetylationAcetyltransferaseBiochemicalBiologicalBiological ProcessBiologyBiophysicsCellsChemicalsDeacetylaseDiseaseEP300 geneEnzymesGenetic TranscriptionGoalsHealthHumanMolecularPathway interactionsPhosphorylationPost-Translational Protein ProcessingProductionProtacProtein AcetylationProtein DatabasesProteinsProteomicsRegulationStructureSystemTherapeuticUbiquitinWorkdesignexperimental studyinsightmolecular recognitionmulticatalytic endopeptidase complexnon-histone proteinnovelnovel therapeutic interventionprotein degradationprotein protein interactionproteostasisrecruittooltranscriptome sequencingubiquitin-protein ligase
中文摘要
摘要
蛋白质动态平衡是维持细胞健康的关键,主要由泛素控制。
蛋白酶体系统(UPS),通过3种酶的级联,用泛素标记蛋白质,从而导致
蛋白酶体的识别和随后的降解。虽然有些蛋白质是结构性识别的
并被该系统降级,其他被翻译后修改标记为UPS的底物
比如磷酸化。近年来,非组蛋白的乙酰化已成为一种重要的机制。
泛素-蛋白酶体系统的调控,特别是在E3连接酶底物识别的水平上。
利用我们在泛素、蛋白酶体和蛋白质-蛋白质相互作用方面的专业知识,我们建议阐明
乙酰化调控蛋白质的分子机制和生物学途径
动态平衡(项目1)。此外,在我们之前针对嵌合体的蛋白质降解工作的基础上,我们将
开发异双功能方法来调节蛋白质的乙酰化状态,作为一种新的控制机制
蛋白质动态平衡对这一基本生物调节的研究和作为一种潜在的治疗方法
方法(项目2)。
在项目1中,我们将鉴定和鉴定在翻译后水平上调节稳定性的蛋白质
乙酰化。使用与RNA-Seq配对的蛋白质组学实验,我们将生成一个蛋白质数据库,其中
细胞内水平由p300驱动的乙酰化直接控制,不在转录水平上改变。
此外,我们还将表征相关的E3对乙酰基降解底物的分子识别作用
使用生物物理、生化和结构方法的连接酶,揭示了对这一机制的独特见解
蛋白质动态平衡。在项目2中,我们将开发异双功能化合物,以招募一个
乙酰转移酶或脱乙酰基酶到新底物。建立在化学诱导后-
翻译修饰,例如针对嵌合体的蛋白质降解,我们将确定(去)乙酰化
在设计和合成之前,最适合于这种方法的机械通过化学生物学方法
在本地系统中编辑乙酰化的化合物。这些项目一起提供了对基础生物学的见解
调节蛋白质稳定性的过程和一种新的化学生物学方法来修饰它们。
英文摘要
Abstract
Protein homeostasis is crucial to maintain healthy cells and is predominantly controlled by the ubiquitin
proteasome system (UPS) whereby proteins are tagged with ubiquitin, via a cascade of 3 enzymes, resulting in
recognition by the proteasome and subsequent degradation. While some proteins are constitutively recognized
and degraded by this system, others are marked as substrates for the UPS by post-translational modifications
such as phosphorylation. Recently, acetylation of non-histone proteins has emerged as an important mechanism
of regulation for the ubiquitin-proteasome system, particularly at the level of E3 ligase substrate recognition.
Leveraging our expertise of the ubiquitin proteasome and protein-protein interactions we propose to elucidate
the molecular mechanisms and biological pathways resulting in acetylation driven modulation of protein
homeostasis (Project 1). Additionally, building on our previous work with proteolysis targeting chimera, we will
develop heterobifunctional approaches to modulate protein acetylation states as a novel mechanism to control
protein homeostasis for both the study of this fundamental biological regulation and as a potential therapeutic
approach (Project 2).
In Project 1, we will identify and characterize proteins with stability regulated at the level of post-translational
acetylation. Using proteomics experiments paired with RNA-Seq we will generate a database of proteins with
intracellular levels directly controlled by p300 driven acetylation, not altered at the level of transcription.
Furthermore, we will characterize the molecular recognition of acetyl degron substrates by the relevant E3
ligases using biophysical, biochemical and structural approaches, revealing unique insights into this mechanism
of protein homeostasis. In Project 2, we will develop heterobifunctional compounds which recruit an
acetyltransferase or deacetylase to a neo-substrate. Building on the concept of chemically induced post-
translational modifications, exemplified by proteolysis targeting chimera, we will identify the (de)acetylation
machinery most amenable to this approach via chemical biology approaches before designing and synthesising
compounds to edit acetylation in native systems.Together these projects provide insights into basic biological
processes regulating protein stability and a novel chemical biology approach to modify them.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Metabolic regulation and inhibition of ATP-citrate lyase
-
批准号:10588229
-
项目类别:
-
资助金额:$62.2万
-
财政年份:2022
-
负责人:George Burslem
-
依托单位:
Metabolic regulation and inhibition of ATP-citrate lyase
-
批准号:10444160
-
项目类别:
-
资助金额:$65.04万
-
财政年份:2022
-
负责人:George Burslem
-
依托单位:
Editing Acetylation and Protein Homeostasis
-
批准号:10457016
-
项目类别:
-
资助金额:$40.63万
-
财政年份:2021
-
负责人:George Burslem
-
依托单位:
Editing Acetylation and Protein Homeostasis
-
批准号:10625387
-
项目类别:
-
资助金额:$40.63万
-
财政年份:2021
-
负责人:George Burslem
-
依托单位:
Editing Acetylation and Protein Homeostasis
-
批准号:10581878
-
项目类别:
-
资助金额:$25.0万
-
财政年份:2021
-
负责人:George Burslem
-
依托单位:
海外基金